Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 and 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05814107
What this trial is testing

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesOverweight or Obesity
Carmot Australia First Pty Ltd 94
Not applicableStudy completedNCT04769167
What this trial is testing

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

Who this might be right for
Congenital Heart DiseaseViremiaVirus Diseases+12 more
Washington University School of Medicine 114
Early research (Phase 1)Study completedNCT00964964
What this trial is testing

A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 18
Not applicableStudy completedNCT01847937
What this trial is testing

Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy+3 more
Aarhus University Hospital 115
Early research (Phase 1)Study completedNCT03611322
What this trial is testing

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 54
Early research (Phase 1)Ended earlyNCT03332836
What this trial is testing

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 21
Not applicableStudy completedNCT00444899
What this trial is testing

Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Université de Sherbrooke 101
Testing effectiveness (Phase 2)Study completedNCT00042471
What this trial is testing

Evaluation of the Bioavailability of Pramlintide

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
AstraZeneca 75
Testing effectiveness (Phase 2)Study completedNCT00370084
What this trial is testing

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

Who this might be right for
Gastroparesis
Forest Laboratories 25
Not applicableUnknownNCT04949022
What this trial is testing

Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

Who this might be right for
Type 1 Diabetes
Helsinki University Central Hospital 38
Large-scale testing (Phase 3)Ended earlyNCT00287651
What this trial is testing

Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, With Complications
Florida Atlantic University 150
Early research (Phase 1)Ended earlyNCT01923389
What this trial is testing

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Pfizer 4
Not applicableNot Yet RecruitingNCT07503366
What this trial is testing

Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies

Who this might be right for
Type 1 Diabetes (T1D)AutoantibodiesHyperglycemia+1 more
Società Italiana di Endocrinologia e Diabetologia Pediatrica 300
Early research (Phase 1)Looking for participantsNCT07803809
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT00998699
What this trial is testing

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
XOMA (US) LLC 22
Not applicableStudy completedNCT00665093
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,569
Early research (Phase 1)Study completedNCT01794364
What this trial is testing

Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

Who this might be right for
Healthy
Pfizer 8
Early research (Phase 1)Study completedNCT04305587
What this trial is testing

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 2
Pfizer 66
Not applicableNot Yet RecruitingNCT07646067
What this trial is testing

Closed Loop Glucose Control in a Simulated ICU Setting

Who this might be right for
Type 1 DiabetesType 2 DiabetesStress Induced Hyperglycemia
Ideal Medical Technologies 6
Not applicableStudy completedNCT00789711
What this trial is testing

An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,131
Next Page